Navigation Links
Treatment Target for Herpes Pinpointed
Date:3/27/2009

Study finds VP16 is molecular key that unlocks the virus from latent state

FRIDAY, March 27 (HealthDay News) -- Researchers have identified a potential new target in the ongoing quest for a treatment, and possibly a cure, for the herpes virus.

A viral protein known as VP16 is apparently responsible for pushing herpes out of its latent state and back into an active infectious state.

Experts estimate that 70 percent to 90 percent of people worldwide carry the herpes virus, although not all show symptoms. "It's a huge, huge epidemic," said study author Nancy Sawtell, a researcher in the division of infectious diseases at Cincinnati Children's Hospital Medical Center. Her report appears in the March 26 issue of PLoS Pathogens.

Herpes is transmitted by close person-to-person contact, often through the mouth or genitals. This study looks specifically at herpes simplex 1, which can cause cold sores and genital lesions. The virus can also cause stromal keritis, the leading cause of infectious blindness.

After infection at the skin surface, the virus travels to nerve cells, where it becomes dormant. Although the virus is infectious while it is replicating at the surface, it is non-infectious during this latent phase.

"About one-quarter of neurons contain latent virus," Sawtell explained. "Periodically, in response to stress, the virus will reactivate. From animal models, we know that the number of neurons that exit latency are very few, about one or two out of 6,000, and these neurons go back to the surface and replicate, potentially spreading the virus."

Scientists have long been mystified by one aspect of this ubiquitous virus: what causes it to exit the latent stage and become infectious again?

"We have been trying to understand the molecular mechanism which regulates entry into the latent cycle, what turns on the latent program, and how does that exit from latent program occur, in an effort to begin to understand how we can control that," Sawtell said.

VP16 is known to be important for starting the lytic, or reproductive, cycle upon infection of a cell. However, "it has been dogma that VP16 is not involved in reactivation from the dormant stage," Sawtell said.

But in this study, which used a mouse model, production of VP16 was a prerequisite for the virus's reactivation.

"Further," Sawtell explained, "latency in the nervous system is favored because VP16 is not transported efficiently to the nerve cell nucleus."

"There's evidence that it's not transported efficiently. VP16 is likely to be left behind, which promotes the establishment of latency," Sawtell said.

In essence, the herpes virus uses VP16 to balance the lytic and dormant stages of its life cycle.

In a second study, this one appearing recently in the online issue of Nature Immunology, a team of Canadian and U.S. researchers say they've discovered one way that the immune system activates itself to hunt down type 1 herpes.

The authors stated that the findings may one day have implications in the fight against HIV and even cancer, in addition to herpes.

More information

The U.S. Centers for Disease Control and Prevention has more on genital herpes.



SOURCES: Nancy Sawtell, Ph.D., researcher, division of infectious diseases, Cincinnati Children's Hospital Medical Center; March 23, 2009, news release, University of Montreal, Canada; March 26, 2009, PLoS Pathogens


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Individualized stroke treatment available for patients, though underutilized
2. New OTC Allergy Treatment Available to Food Allergy Sufferers
3. Combating weight gain caused by antipsychotic treatments
4. Autism Study Finds Significant Benefit with Hyperbaric Treatment
5. NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
6. Surveyed Experts Indicate that Biogen Idecs Adentri Has Advantages Over Nitroglycerin in the Treatment of Acute Heart Failure
7. Autism Website Relaunches to Offer Resources, Treatments and Hope for Families
8. Exercise Physiologist and Celebrity Trainer Bob Greene Leads National Campaign to Showcase Osteoarthritis Pain Management Techniques and New Treatment Approaches
9. FDA Approves New Indication for Wyeths TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
10. Record number of patients seek laser treatments to take lightyears off their faces
11. New stem cell therapy may lead to treatment for deafness
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Treatment Target for Herpes Pinpointed
(Date:7/20/2017)... ... July 19, 2017 , ... Adolfson & Peterson Construction ... Josh Christensen. As a leader in healthcare construction, AP has successfully built several ... in the Midwest with Josh now on board. , Josh brings over ...
(Date:7/18/2017)... Sherman Oaks, CA (PRWEB) , ... July 18, 2017 , ... ... and Ph.D. scientist extracted cannabis oils, announced today that at the WORLDZ Summit, taking ... Ryan will be speaking on the therapeutic benefits of medical cannabis for both pediatric ...
(Date:7/18/2017)... ... , ... An inventor from Anacortes, Wash., knows the difficulties and indignity of ... flashes, and I suffer from anxiety and vertigo on top of that," she said, ... about." INSTA-FAN meets that need. , This device enables a woman in menopause to ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... and Its Treatments during Pregnancy , studies take a closer look at maternal ... a developing baby with one study showing newer medications may be safer choices. ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... today announced a partnership with the Texas Academy of Family Physicians (TAFP) ... place October 20-22, 2017 at the Hyatt Regency Dallas in Dallas, Texas.     , ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... 2017 Endo International plc (NASDAQ: ENDP ) ... 2017.  Members of its senior management team will host a conference ... a.m. ET. The dial-in number to access the ... 509-7598, and the passcode is 45397076. Please dial in 10 minutes ... A replay of the call will be available from ...
(Date:7/13/2017)...  New York City-based market research firm Kalorama Information notes ... of.  From new products to new costs, to the threat ... completed study, Potential Pipeline Disruptors . Among ... 1.  Age-Driven Growth - True Impact Moment Arriving   ... impact the growing population and, to a more extreme extent, ...
(Date:7/11/2017)... N.J. , July 11, 2017  Bayer has awarded ... eight countries as part of its prestigious Bayer Hemophilia Awards ... Hospital of Philadelphia and Uniformed Services ... are among the winners. Grant recipients were announced last ... and Hemostasis (ISTH) 2017 Congress, Berlin, Germany ...
Breaking Medicine Technology: